|
 |
| home > ebr > spring 2004 > preparing for the due diligence process - plan your way to success |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
Anyone who has been through a due diligence process will remember it as a painful, time-consuming and frustrating process, but something that has to be endured to get the transaction done. The secret to managing the process is to be organised and plan the process properly. As the target, you must be clear about where the perceived value in the business will be and what will be asked of you. And as the acquirer, you will need to be clear about the business rationale for the transaction and what the key issues for your business are. Verification in the listing process is probably the most exhaustive due diligence process. Therefore, an understanding of what is involved, why it is necessary and the issues that need to be anticipated and planned for can avoid problems and save time later. In our experience, deals run more smoothly and the costs are significantly reduced when the process is properly planned and all the information is readily available. Moreover, a potential purchaser of, or a venture capitalist looking to invest in, a target that has a well-organised and efficient due diligence process, will be left with a strong impression of an effective and able management team, and is less likely to find surprises, ensuring that a company gets maximum value. For companies in the life sciences area, their main asset is likely to be intellectual property. As a consequence, it is likely that any due diligence will focus on assessing the value of their intellectual property, how it is being exploited and how robust their rights are from infringement by third parties.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
